Group One Trading, L.P. Clearside Biomedical, Inc. Transaction History

Group One Trading, L.P.

$3.01 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.93 - $1.66 $1,475 - $2,634	1,587 New	1,587 $1,000
Q3 2022 Nov 09, 2022	SELL	$1.08 - $1.83 $21,600 - $36,600	-20,000 Reduced 88.31%	2,648 $3,000
Q2 2022 Aug 11, 2022	SELL	$1.3 - $2.49 $1,560 - $2,988	-1,200 Reduced 5.03%	22,648 $33,000
Q1 2022 May 12, 2022	SELL	$1.35 - $2.88 $187,655 - $400,331	-139,004 Reduced 85.36%	23,848 $55,000
Q4 2021 Feb 11, 2022	BUY	$2.72 - $5.72 $366,248 - $770,198	134,650 Added 477.45%	162,852 $448,000
Q3 2021 Nov 12, 2021	BUY	$4.83 - $7.2 $136,215 - $203,054	28,202 New	28,202 $169,000
Q1 2021 May 12, 2021	SELL	$2.24 - $4.25 $10,102 - $19,167	-4,510 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$1.32 - $2.74 $5,953 - $12,357	4,510 New	4,510 $12,000
Q3 2020 Nov 12, 2020	SELL	$1.45 - $2.0 $823,459 - $1.14 Million	-567,903 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.55 - $2.41 $141,237 - $219,601	91,121 Added 19.11%	567,903 $1.07 Million
Q1 2020 May 13, 2020	BUY	$1.32 - $3.77 $428,534 - $1.22 Million	324,647 Added 213.39%	476,782 $811,000
Q4 2019 Feb 10, 2020	BUY	$0.62 - $3.4 $94,323 - $517,259	152,135 New	152,135 $441,000
Q3 2019 Nov 12, 2019	SELL	$0.59 - $1.32 $21,424 - $47,931	-36,312 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$1.1 - $1.74 $27,394 - $43,332	24,904 Added 218.3%	36,312 $50,000
Q4 2018 Feb 06, 2019	SELL	$1.0 - $6.12 $3,900 - $23,868	-3,900 Reduced 25.48%	11,408 $12,000
Q3 2018 Nov 08, 2018	SELL	$6.03 - $11.24 $81,953 - $152,762	-13,591 Reduced 47.03%	15,308 $94,000
Q2 2018 Aug 14, 2018	BUY	$8.91 - $14.54 $246,397 - $402,089	27,654 Added 2221.2%	28,899 $309,000
Q1 2018 May 11, 2018	BUY	$5.57 - $14.28 $6,934 - $17,778	1,245 New	1,245 $13,000

Others Institutions Holding CLSD

# of Institutions

Shares Held

13.4M

Call Options Held

17.6K

Put Options Held

100

View Full List

About Clearside Biomedical, Inc.

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

More about CLSD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account